Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes

Shobana Ganesan1, Matthew K Ito

  • 1Department of Pharmacy Practice, College of Pharmacy, Oregon State University/ Oregon Health & Science University, Portland, OR 97239, USA.

Abstract

Insights

Lipophilic statins like simvastatin reduce glucose transporter-4 (GLUT4) protein in fat cells, potentially increasing diabetes risk. Coenzyme Q10 (CoQ10) may prevent this effect, offering a new preventive strategy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Statins effectively lower cardiovascular events in hyperlipidemia patients.
  • A subset of patients on statins develop new-onset diabetes, with unclear mechanisms.
  • Understanding statin-induced diabetes mechanisms is crucial for developing preventive strategies.

Purpose of the Study:

  • To investigate the differential effects of lipophilic (simvastatin) and hydrophilic (pravastatin) statins, and ezetimibe on glucose transporter-4 (GLUT4) protein expression in adipocytes.
  • To determine if coenzyme Q10 (CoQ10) can prevent statin-induced reductions in GLUT4 protein.

Main Methods:

  • Utilized 3T3-L1 adipocytes differentiated with a hormonal cocktail.
  • Assessed GLUT4 protein expression using the In-Cell Western technique.
  • Treated cells with simvastatin, pravastatin, ezetimibe, and CoQ10, individually and in combination.

Main Results:

  • Simvastatin significantly decreased GLUT4 protein expression in adipocytes.
  • Ezetimibe alone or pravastatin did not significantly alter GLUT4 protein levels.
  • Co-treatment with CoQ10 did not significantly prevent the reduction in GLUT4 protein observed with simvastatin.

Conclusions:

  • Lipophilic statins, such as simvastatin, reduce GLUT4 protein levels in adipocytes, unlike hydrophilic statins or ezetimibe.
  • Coenzyme Q10 (CoQ10) co-treatment showed a trend towards preventing simvastatin-induced GLUT4 reduction, warranting further investigation.
  • Findings suggest a potential mechanism for statin-induced diabetes and a possible preventive role for CoQ10.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...